Sugi Predict

Sugi Predict / Compounds / SCHEMBL3074979

SCHEMBL3074979

SCHEMBL3074979

CCCc1nc2c(N)ncnc2n1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSPA8 P11142 4/20 0.72
▸ HSPA5 P11021 2/20 0.72
▸ RXFP1 Q9HBX9 1/20 0.69
▸ ADORA3 P0DMS8 3/20 0.65
▸ SMN1; SMN2 Q16637 2/20 0.65
▸ LMNA P02545 1/20 0.65
▸ TP53 P04637 1/20 0.65
▸ HBB P68871 1/20 0.65
▸ GAPDH P04406 3/20 0.63
▸ HSD17B10 Q99714 1/20 0.63
▸ SLC28A2 O43868 3/20 0.61
▸ AMD1 P17707 1/20 0.58
▸ DPP4 P27487 1/20 0.57
▸ MEN1 O00255 1/20 0.57
▸ SLC28A1 O00337 1/20 0.57
▸ MAP3K7 O43318 1/20 0.57
▸ MAPK1 P28482 1/20 0.57
▸ ADORA2A P29274 1/20 0.57
▸ ADORA2B P29275 1/20 0.57
▸ ADORA1 P30542 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3074984 1.00 HSPA8 (0.72) HSPA8HSPA5RXFP1ADORA3SMN1; SMN2
SCHEMBL1097926 0.91 HSPA8 (0.75) HSPA8HSPA5RXFP1ADORA3SMN1; SMN2
SCHEMBL1097934 0.91 HSPA8 (0.75) HSPA8HSPA5RXFP1ADORA3SMN1; SMN2
SCHEMBL6825727 0.90 HSPA8 (0.73) HSPA8HSPA5RXFP1ADORA3SMN1; SMN2
SCHEMBL7027923 0.89 HSPA8 (0.72) HSPA8HSPA5RXFP1ADORA3SMN1; SMN2
SCHEMBL5672454 0.87 HSPA8 (0.69) HSPA8HSPA5RXFP1ADORA3SMN1; SMN2
SCHEMBL4376144 0.87 HSPA8 (0.69) HSPA8HSPA5RXFP1ADORA3SMN1; SMN2
SCHEMBL5672460 0.87 HSPA8 (0.69) HSPA8HSPA5RXFP1ADORA3SMN1; SMN2
SCHEMBL6897817 0.86 HSPA8 (0.68) HSPA8HSPA5RXFP1ADORA3SMN1; SMN2
SCHEMBL15906323 0.85 HSPA8 (0.80) HSPA8HSPA5RXFP1ADORA3SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8633168-B2 Inhibitors of S-adenosyl-L-methionine decarboxylase GENZYME CORPORATION (US) 2014-01-21 — — US disclosed
US-8633168-B2 Inhibitors of S-adenosyl-L-methionine decarboxylase GENZYME CORPORATION (US) 2014-01-21 — — US disclosed
US-8633168-B2 Inhibitors of S-adenosyl-L-methionine decarboxylase GENZYME CORPORATION (US) 2014-01-21 — — US disclosed
US-20100261668-A1 INHIBITORS OF S-ADENOSYL-L-METHIONINE DECARBOXYLASE GENZYME CORPORATION 2010-10-14 — — US disclosed
US-20100261668-A1 INHIBITORS OF S-ADENOSYL-L-METHIONINE DECARBOXYLASE GENZYME CORPORATION 2010-10-14 — — US disclosed
US-20100261668-A1 INHIBITORS OF S-ADENOSYL-L-METHIONINE DECARBOXYLASE GENZYME CORPORATION 2010-10-14 — — US disclosed
WO-2008157438-A1 INHIBITORS OF S-ADENOSYL-L-METHIONINE DECARBOXYLASE GENZYME CORPORATION (US) 2008-12-24 — — WO disclosed
WO-2008157438-A1 INHIBITORS OF S-ADENOSYL-L-METHIONINE DECARBOXYLASE GENZYME CORPORATION (US) 2008-12-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100261668-A1 INHIBITORS OF S-ADENOSYL-L-METHIONINE DECARBOXYLASE AMD1, MAT1A, AHCY HSPA8 2972/4885HSPA5 4426/4885RXFP1 4642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.